This inventor holds 31 USPTO granted patents and 3 EPO patents, primarily in Medicinal Chemistry. Top assignees: Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.), Ipsen Pharma S.a.s., Adir Et Compagnie. Active years: 1994-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boulogne sur Seine, FR (1994 - 1995)
- Paris, FR (1996 - 2012)
Company Filing History:
11 out of 119 
7 out of 108 
6 out of 368 
Years Active: 1994-2012
Areas of Expertise:
Title: Innovations and Contributions of Christophe Thurieau
Introduction
Christophe Thurieau is a prominent inventor based in Paris, France, known for his significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 31 patents, Thurieau has been at the forefront of developing innovative compounds that are instrumental in therapeutic applications.
Latest Patents
Among his latest innovations are two noteworthy patents. The first is for "Derivatives of heterocycles with 5 members, their preparation and their use as medicaments." This invention pertains to various derivatives such as thiazole, oxazole, imidazole, isoxazole, and isoxazoline, which have beneficial pharmacological properties. These compounds are aimed at treating neurodegenerative disorders and alleviating pain. The second patent concerns "Peptide-cytotoxic conjugates," which involve targeted cytotoxic compounds and methodologies for their therapeutic use, particularly for the treatment of neoplasia and other medical conditions.
Career Highlights
Thurieau has established his career in reputable organizations, including the Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and Ipsen Pharma S.A.S. His work at these companies has contributed to advancing pharmaceutical research and the development of therapeutic agents that cater to critical medical needs.
Collaborations
Throughout his career, Christophe has collaborated with several talented individuals, notably Lydie Francine Poitout and Christophe Moinet. These collaborations have fostered innovative approaches and enhanced the effectiveness of the research efforts in which they were involved.
Conclusion
Christophe Thurieau's dedication to innovation in medicinal chemistry is evident through his extensive patent portfolio and collaborative work in the industry. His contributions not only advance the scientific community but also provide valuable solutions to health challenges, showcasing the importance of innovation in the development of therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile